Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Am J Prev Med. 2018 May 14;55(1):1–10. doi: 10.1016/j.amepre.2018.03.011

Table 1.

Definitions of Eligibility for and Utilization of Each Preventive Service, 2008–2015 (Individuals Aged 50–75 Years)

Preventive service Definition of eligibility Definition of utilization
Tobacco cessation23 Current smoker Former smoker
Obesity control24,25 BMI ≥30 kg/m2 Weight loss of ≥5%a
Hypertension control26 Blood pressure ≥140/90 mmHgb Blood pressure <140/90 mmHgb
Lipids control27,28 LDL-C ≥130 mg/dL for non-diabetics, ≥100 mg/dL for diabeticsc LDL <130 mg/dL for non-diabetics, <100 mg/dL for diabeticsc
Blood glucose control29 Diagnosis with diabetes and HbA1c ≥7% HbA1c <7.0%
Breast cancer screening30 Women with no mammogram in past 2 years, in women without bilateral mastectomy Receipt of mammography
Cervical cancer screening31 In women aged <65 years and without prior hysterectomy, no Pap test in past 3 years or no Pap+HPV co-testing in past 5 years Pap test, with or without HPV testing
Colorectal cancer screening32 Colonoscopy in past 10 years, flexible sigmoidoscopy in past 5 years, or fecal occult blood testing in past 1 year Receipt of colonoscopy, flexible sigmoidoscopy or fecal occult blood testing
Abdominal aortic aneurysm screening33 Men aged 65–75 years who ever smoked with no record of screening Receipt of screening
Osteoporosis screening34 Women aged ≥65 years Receipt of osteoporosis screening
Influenza vaccination All individuals Receipt of influenza vaccine
a

Weight loss ≥10% in sensitivity analysis.

b

Average of three latest visits in each calendar year, if they occurred within 90 days of each other.

c

Based on ATP III criteria,28 which were in place during the majority of this study.

LDL-C, low density lipoprotein cholesterol; HPV, human papilloma virus; ATP III, Adult Treatment Panel III; HbA1c, glycated hemoglobin.